Lupin Appoints Brian Savage as President and Chief Legal Officer
Lupin Ltd 路 Press Release 路 23 Oct 2026, 3:29 pm
Lupin Appoints Brian Savage as President and Chief Legal Officer Lupin Limited announced the appointment of Brian Savage as President, Chief Legal Officer on 23rd Oct'26. Based in New Jersey, Savage will oversee the company's global Legal, Compliance, and Intellectual Property Management Group functions. He joins from Teva Pharmaceuticals, where he served since 2015 in senior leadership roles, most recently as Executive Vice President and Interim Global Chief Legal Officer, as well as General Counsel for U.S. Generics. The strategic hire aims to strengthen Lupin鈥檚 governance framework and global regulatory navigation.
Original exchange filing (PDF)
More announcements from Lupin Ltd
- Lupin Announces European Launch of Biosimilar Ranibizumab. 路 12 Nov 2026
- Transcript of Q2 FY2027 Earnings Conference Call. 路 07 Nov 2026
- Link of Audio recording of the Earnings Call-Q2 FY27. 路 05 Nov 2026
- Investor Presentation- Q2 FY2027 路 04 Nov 2026
- Lupin Q2 FY2027 Results 路 04 Nov 2026
- Appointment of Mr. Akhil Gupta as an Additional Director (Non-Executive, Independent) effective November 03, 2026 and as an Independent Director for a term of five consecutive years with .... 路 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
